Showing results (501-510 of 559) with videos related to
Sort By:
Pageof 56
NPJ Regenerative Medicine|August 8, 2025
Supramolecular nanostructure mimics GDNF trophic effects in vitro on human dopaminergic neuronsOscar A Carballo-Molina, Alexandra N Kolberg-Edelbrock, Matías Alvarez-Saavedra, et al.Oncogene|June 20, 1996
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cellsS S Bacus, Y Yarden, M Oren, et al.American Heart Journal|January 21, 2014
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized studyKelly M Chin, David B Badesch, Ivan M Robbins, et al.The Journal of Infectious Diseases|November 4, 2020
Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across UgandaVictor Asua, Melissa D Conrad, Ozkan Aydemir, et al.Nature Communications|June 21, 2018
Covalent-supramolecular hybrid polymers as muscle-inspired anisotropic actuatorsStacey M Chin, Christopher V Synatschke, Shuangping Liu, et al.AJOB Empirical Bioethics|March 17, 2020
Informed Consent in Two Alzheimer's Disease Research Centers: Insights From Research CoordinatorsChristine M Suver, Jennifer K Hamann, Erin M Chin, et al.Journal of Internal Medicine|April 5, 2023
Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosisBinu V John, Dustin Bastaich, Gwilym Webb, et al.Annals of the Academy of Medicine, Singapore|April 18, 2002
Penile colour duplex ultrasonography as a screening tool for venogenic erectile dysfunctionH S Teh, M B K Lin, I Y Y Tsou, et al.JMIR Research Protocols|April 13, 2021
The United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol for a Prospective, Longitudinal StudyKim M Kerr, C Greg Elliott, Raymond L Benza, et al.Journal of Racial and Ethnic Health Disparities|August 5, 2025
Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and EthnicityHarrison W Farber, Murali M Chakinala, Anna R Hemnes, et al.Pageof 56